Related Articles
Valganciclovir and bevacizumab for recurrent glioblastoma: A single-institution experience
Disease progression patterns of bevacizumab responders with recurrent malignant gliomas
Bevacizumab treatment for newly diagnosed glioblastoma: Systematic review and meta-analysis of clinical trials
Bevacizumab as a last-line treatment for glioblastoma following failure of radiotherapy, temozolomide and lomustine
Promoter methylation and expression analysis of MGMT in advanced pediatric brain tumors